The American Association of Clinical Endocrinology (AACE) - Comprehensive Analysis Report

Summary

The American Association of Clinical Endocrinology (AACE) is a global professional medical organization founded in 1991, serving over 5,900 clinical members and 30,000 healthcare professionals worldwide. Initially established to provide a voice for clinical endocrinologists in health policymaking and professional societies, AACE underwent a brand refresh in 2020. The organization is a vital hub for knowledge and experience in clinical endocrinology, committed to defining optimal patient care, preventing disease, educating multidisciplinary care teams and patients, and disseminating accurate information about endocrine diseases. AACE's mission is "elevating the practice of clinical endocrinology to improve global health," with a vision to achieve healthier communities through endocrine innovation, education, and care. Core values include being patient-care centered, inclusive, collaborative, excellent, and innovative, underscoring its pivotal role in advancing global endocrine health.

1. Strategic Focus & Objectives

Core Objectives

AACE's strategic direction for 2026–2029 is anchored on three foundational goals designed to enhance its influence and support within the endocrine community:

Be the Professional Home for Clinical Endocrinologists & the Endocrine Care Team: This objective focuses on delivering high-quality clinical and practice-based education, fostering leadership and career development for its members, actively listening and responding to the global endocrine community's needs, and supporting the growth and expansion of the clinical endocrinology workforce.
Define, Advocate, & Influence Quality Endocrine Care for All: This goal aims to disseminate pioneering endocrine research and knowledge, develop and distribute authoritative clinical guidelines, consensus statements, and practice standards. It also involves establishing advocacy priorities, resources, and partnerships that benefit both patients and the profession, while actively promoting the value of endocrinologists and the broader endocrine care team.
Engage the Global Endocrine Community to Advance Knowledge & Patient Health: This objective seeks to establish AACE as a trusted source for patient education in endocrinology, strengthen partnerships with domestic and international societies and organizations, and continuously deliver value and innovation to the entire endocrine community.

These strategic goals are supported by key enablers such as transparent communications, member insights, endocrine partnerships, technology innovation, operational excellence, and financial sustainability.

Specialization Areas

AACE specializes in defining and promoting optimal patient care and disease prevention pathways across the spectrum of endocrine and metabolic disorders. Its expertise extends to educating multidisciplinary care teams and patients, as well as disseminating accurate, evidence-based information pertaining to endocrine diseases. The organization is a leader in developing clinical guidelines, consensus statements, and practice standards for clinical endocrinology.

Target Markets

AACE primarily targets clinical endocrinologists and the broader endocrine care team, serving as their professional home. It also addresses the needs of patients suffering from endocrine disorders through education and advocacy. Furthermore, AACE aims to engage the global endocrine community, including other medical societies and organizations, to advance knowledge and patient health worldwide.

2. Product Pipeline

Key Products/Services

AACE offers a comprehensive suite of services and educational initiatives designed to advance the practice of clinical endocrinology and improve patient outcomes:

Clinical and Practice-Based Education: Provides high-quality educational content for clinical endocrinologists and the endocrine care team through various formats.
Clinical Guidelines, Consensus Statements, and Practice Standards: Develops and widely distributes authoritative documents that establish best practices for managing endocrine diseases.
Advocacy Initiatives: Leads efforts to establish advocacy priorities, resources, and partnerships to benefit both patients and the endocrinology profession, influencing health policymaking.
Patient Education: Creates and disseminates trusted information and resources for patients to help them understand and manage endocrine diseases.
Annual Meeting: Hosts a major annual conference (e.g., the 35th Annual Meeting in April 2026) featuring expert speakers and sessions covering a wide range of endocrine disease states, with a focus on nutrition, obesity management, and clinical innovations.
Endocrine University: Offers a specialized educational program for in-depth learning in endocrinology.
Digital Content: Delivers brand awareness and sponsored content through podcasts, webinars, articles, and videos, alongside digital advertising on its websites.

3. Technology & Innovation

Technology Stack

AACE is committed to leveraging technology innovation as a strategic enabler to achieve its goals. This includes enhancing digital tools and platforms to facilitate global collaborations, improve communication, and expand the reach of its educational programs and patient resources. The organization aims to continuously innovate its technology to deliver value to the endocrine community and combat misinformation effectively.

4. Leadership & Management

Executive Team

AACE's Board of Directors comprises elected leaders who guide the organization's strategic direction. Key officers for 2026 include:

President: Dace L. Trence, MD, MACE. Dr. Trence is recognized for her dedication to excellence in endocrine education, innovation, and patient-centered care. She is a respected clinician, educator, and leader in the field.
President-Elect: Leslie S. Eldeiry, MD, ECNU, FACE.
Treasurer: Kenneth E. Izuora, MD, MBA, FACE.
Secretary: Geetha Gopalakrishnan, MD, FACE.
Immediate Past President: Scott D. Isaacs, MD, FACP, FACE.
Chief Executive Officer (CEO): Johnnie White, MBA, CAE, CMP Fellow. Mr. White joined AACE with over 30 years of results-focused association leadership experience, including work with national healthcare societies and advocacy for endocrinologists and endocrine care teams.

Recent Leadership Changes

Johnnie White, MBA, CAE, CMP Fellow, assumed the role of Chief Executive Officer for AACE effective March 1, 2024. In January 2026, Dace L. Trence, MD, MACE, was welcomed as the new AACE President, succeeding Scott D. Isaacs, MD, FACP, FACE, who concluded his tenure as President in 2025.

5. Talent and Growth Indicators

Hiring Trends and Workforce

AACE is dedicated to supporting the expansion of the clinical endocrinology workforce as a core strategic objective. The organization embraces a global, inclusive community model, currently comprising over 5,900 endocrine-focused clinical members in the United States and more than 90 other countries. Its broader community encompasses over 30,000 healthcare professionals. The strategic plan for 2026–2029 emphasizes strengthening the organization's position as "the professional home for clinical endocrinologists & the endocrine care team" and expanding its membership and educational offerings, indicating a focus on steady growth and reaching a broader audience.

6. Social Media Presence and Engagement

Digital Footprint

AACE actively engages its community and disseminates information through a robust presence on various social media platforms, encouraging conversation with the hashtag #aace.

Twitter/X: @aace
Facebook: AACE (formerly facebook.com/aace1947)
LinkedIn: AACE
Instagram: aaceconnects

The organization utilizes social media to share news, provide event updates, and convey essential information, prompting followers to remain informed. AACE leverages platforms like Facebook for live-streamed "Engagement Lounges," an initiative aimed at fostering community and expanding AACE's reach to a wider audience. Key messaging consistently revolves around its core objectives, promoting patient education, and accentuating the invaluable role of endocrinologists in healthcare.

7. Recognition and Awards

Industry Recognition

AACE celebrates significant accomplishments and contributions within the endocrinology community through its annual awards program. These awards honor individuals who demonstrate excellence across various domains, including clinical practice, education, research, public health, medical ethics, technological innovations, medical advancements, and community involvement.

Specific awards granted by AACE include:

Yank D. Coble, Jr., MD, Distinguished Service Award: Recognizes outstanding service by AACE members.
Eugene T. Davidson, MD, Public Service Award: Honors contributions to public health and service.
Alan J. Garber, MD, PhD, MACE, Lectureship: A prestigious lectureship acknowledging significant contributions in the field.
Hossein Gharib, MD, MACP, MACE Educational Lectureship: Recognizes excellence in educational contributions within endocrinology.
Distinguished Associate Award: Recognizes significant contributions by non-physician professionals.

AACE’s commitment to recognizing excellence reinforces its dedication to elevating the practice and impact of clinical endocrinology.

8. Market Analysis

Market Overview

The field of clinical endocrinology addresses a wide array of endocrine and metabolic disorders, including diabetes, obesity, thyroid disease, bone and parathyroid disease, lipid and cardiovascular health, pituitary, gonad, adrenal, and neuroendocrine disorders. These conditions collectively impact tens of millions of patients annually, signifying a substantial and continuous demand for expert endocrine care.

AACE plays a critical role in this extensive market by defining best practices, educating healthcare professionals, and advocating for high-quality care. The organization has notably contributed to the recognition of obesity as a disease state, having been the primary sponsor of the resolution adopted by the American Medical Association in 2013 to officially recognize obesity as a disease. The increasing global prevalence of chronic endocrine diseases underscores the persistent need for advancements in clinical endocrinology and the vital services provided by organizations like AACE.

9. Strategic Partnerships

AACE engages in diverse strategic collaborations and partnerships to advance its mission and improve patient care outcomes fundamentally.

Corporate AACE Partnership (CAP): This two-tiered program fosters collaboration between industry partners and AACE. It offers year-round opportunities for industry to engage with AACE physician leaders and community members, focusing on advancing patient care. This includes CME Education Grant Support, Brand Awareness and Sponsored Content (podcasts, webinars, articles, videos), Digital Advertising on AACE websites, and participation in live meetings such as the Annual Meeting and Endocrine University.
Medical Specialty and Healthcare Organizations: AACE collaborates with other medical specialties and healthcare organizations to advance endocrine care. Historically, it has partnered with domestic organizations such as the American Diabetes Association and American Thyroid Association.
International Collaborations: Globally, AACE has formed partnerships with entities like the International Diabetes Federation and the European Association for the Study of Diabetes, expanding its international reach and influence.
Advocacy Partnerships: The organization actively works to establish advocacy partnerships that provide mutual benefits for both patients and the endocrinology profession, influencing policy and public awareness.

10. Operational Insights

Current Market Position

AACE holds a prominent position as a global, inclusive community and professional home for clinical endocrinologists and endocrine care teams. It is recognized as a vital hub for knowledge and experience in clinical endocrinology, actively defining optimal patient care and disease prevention pathways.

Competitive Advantages

AACE's competitive advantages stem from its singular focus on clinical endocrinology, providing a dedicated voice for its members in national and international health policymaking. Its extensive network of over 5,900 clinical members and 30,000 healthcare professionals, coupled with its commitment to developing authoritative clinical guidelines and patient education, solidifies its leadership in the field. The organization's early and influential advocacy, such as successfully campaigning for the recognition of obesity as a disease by the American Medical Association, demonstrates its impactful stance on critical health issues.

Operational Strengths

Key operational strengths include its robust educational offerings (Annual Meeting, Endocrine University, diverse digital content), a strong advocacy platform that influences policy and promotes the value of endocrinologists, and a dedicated focus on developing and disseminating clinical guidelines and practice standards. AACE’s ability to foster both domestic and international partnerships further strengthens its reach and impact.

Areas for Improvement

The strategic plan references "transparent communications, member insights, technology innovation, operational excellence, and financial sustainability" as strategic enablers. While these are strengths, they also represent ongoing areas for continuous improvement and refinement to ensure AACE remains at the forefront of the field and effectively meets the evolving needs of its community. Enhancing digital tools and global collaborations are explicitly mentioned as ongoing efforts to expand influence and combat misinformation.

11. Future Outlook

Strategic Roadmap

AACE's 2026–2029 Strategic Plan outlines a clear roadmap for its future, centered on strengthening its role as the professional home for clinical endocrinologists and the endocrine care team, while defining and advocating for quality endocrine care globally.

Key initiatives and growth strategies include:

Workforce Expansion: Supporting and fostering the growth of the endocrinology workforce to meet increasing demand.
Educational Excellence: Delivering high-quality education through new membership offerings, innovative programs, and continued development of resources like the Annual Meeting and Endocrine University.
Guideline Development: Continuing to develop and disseminate impactful clinical guidelines, consensus statements, and practice standards.
Policy Advocacy: Strengthening advocacy efforts to influence policies that benefit both patients and the profession.
Digital Enhancement: Enhancing digital tools and platforms to facilitate broader global collaborations and expand its worldwide influence.
* Patient Empowerment: Becoming a globally trusted source for accurate patient information to actively combat misinformation, providing accessible and reliable resources.

AACE plans to measure its progress through key performance indicators such as membership growth, the effectiveness of its programs, and its overall organizational impact on global health. The upcoming 35th Annual Meeting in April 2026 will serve as a significant platform for advancing endocrine practice, emphasizing nutrition, obesity management, and clinical innovations